Exchange Traded Concepts, LLC Moderna, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.74 Billion
  • Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 26,137 shares of MRNA stock, worth $1.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26,137
Previous 17,558 48.86%
Holding current value
$1.07 Million
Previous $1.17 Million 7.42%
% of portfolio
0.02%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
BUY
$36.85 - $63.93 $316,136 - $548,455
8,579 Added 48.86%
26,137 $1.09 Million
Q3 2024

Oct 10, 2024
BUY
$63.64 - $125.14 $694,121 - $1.36 Million
10,907 Added 163.99%
17,558 $1.17 Million
Q2 2024

Aug 13, 2024
SELL
$101.21 - $166.61 $509,288 - $838,381
-5,032 Reduced 43.07%
6,651 $789,000
Q1 2024

Apr 15, 2024
SELL
$85.37 - $115.44 $144,872 - $195,901
-1,697 Reduced 12.68%
11,683 $1.24 Million
Q4 2023

Jan 05, 2024
BUY
$69.51 - $104.43 $45,807 - $68,819
659 Added 5.18%
13,380 $1.33 Million
Q3 2023

Oct 18, 2023
SELL
$96.41 - $126.61 $2.3 Million - $3.02 Million
-23,824 Reduced 65.19%
12,721 $1.31 Million
Q2 2023

Jul 20, 2023
BUY
$118.5 - $160.53 $2.56 Million - $3.47 Million
21,623 Added 144.91%
36,545 $4.44 Million
Q1 2023

Apr 12, 2023
BUY
$135.66 - $197.02 $202,404 - $293,953
1,492 Added 11.11%
14,922 $2.29 Million
Q4 2022

Jan 17, 2023
SELL
$118.38 - $210.04 $329,806 - $585,171
-2,786 Reduced 17.18%
13,430 $2.41 Million
Q3 2022

Oct 07, 2022
BUY
$118.07 - $194.18 $477,238 - $784,875
4,042 Added 33.2%
16,216 $1.92 Million
Q2 2022

Jul 20, 2022
SELL
$117.13 - $176.59 $341,433 - $514,759
-2,915 Reduced 19.32%
12,174 $1.74 Million
Q1 2022

Apr 26, 2022
BUY
$126.46 - $235.05 $475,616 - $884,023
3,761 Added 33.2%
15,089 $2.6 Million
Q4 2021

Jan 13, 2022
BUY
$225.82 - $368.51 $211,367 - $344,925
936 Added 9.01%
11,328 $2.88 Million
Q3 2021

Oct 18, 2021
BUY
$221.9 - $484.47 $547,205 - $1.19 Million
2,466 Added 31.11%
10,392 $4 Million
Q2 2021

Jul 30, 2021
SELL
$129.91 - $234.98 $442,603 - $800,576
-3,407 Reduced 30.06%
7,926 $1.86 Million
Q1 2021

Apr 20, 2021
BUY
$109.18 - $185.98 $585,423 - $997,224
5,362 Added 89.8%
11,333 $1.48 Million
Q4 2020

Jan 19, 2021
BUY
$65.74 - $169.86 $38,326 - $99,028
583 Added 10.82%
5,971 $624,000
Q3 2020

Oct 30, 2020
BUY
$54.34 - $94.85 $117,048 - $204,306
2,154 Added 66.6%
5,388 $381,000
Q2 2020

Jul 15, 2020
BUY
$29.67 - $80.0 $15,458 - $41,680
521 Added 19.2%
3,234 $208,000
Q1 2020

Apr 14, 2020
BUY
$17.78 - $31.58 $48,237 - $85,676
2,713 New
2,713 $81,000

Others Institutions Holding MRNA

# of Institutions
912
Shares Held
239M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email